Endoscopy 2007; 39(2): 168-173
DOI: 10.1055/s-2007-966182
Special article

© Georg Thieme Verlag KG Stuttgart · New York

Current status of screening colonoscopy in Europe and in the United States

C.  Pox1, 3 , W.  Schmiegel1, 3, 4 , M.  Classen2, 3, 4
  • 1Department of Internal Medicine, Ruhr-University Bochum, Bochum, Germany
  • 2Department of Internal Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany
  • 3 German Society for Digestive and Metabolic Diseases
  • 4 International Digestive Cancer Alliance
Further Information

Publication History

Publication Date:
27 February 2007 (online)

Introduction

Colonoscopy screening for colorectal cancer and adenoma is already being practiced in the United States and in some European countries and it is being studied in others. In order to compare the experience gained to date and to discuss the existing evidence concerning endoscopic screening, a 1-day workshop entitled “Eurocolonoscopy” was held in Frankfurt am Main, Germany, on 10 May 2006. The workshop was organized by representatives of the European Society of Gastrointestinal Endoscopy (ESGE), the International Digestive Cancer Alliance (IDCA), the German Society of Digestive and Metabolic Diseases (DGVS), and the German Network against Colorectal Cancer, by participants from European countries where endoscopic screening is practiced, and by one representative from the United States. The workshop began with an overview of the screening conditions specific to each country, and this was followed by a general discussion about colonoscopy screening. This article summarizes the current status of colonoscopy screening in Europe and the United States.

Colorectal cancer (CRC) is now the commonest malignant tumor in Europe (excluding the Russian Federation) [1]. The overall 5-year survival rate is only around 50 % and the prognosis for advanced disease remains poor in spite of recent advances in treatment. The most important prognostic factor for CRC is disease stage at diagnosis [2]. To reduce CRC-related mortality, screening of asymptomatic population groups has been recommended [3] [4] [5] [6]. The aims of screening are to detect carcinomas at an early, asymptomatic stage and to reduce the incidence of CRC by detecting and removing adenomatous polyps, which are usually the precursor lesions of CRC.

There are several different screening methods available, including fecal occult blood testing (FOBT), flexible sigmoidoscopy, and colonoscopy. Most American screening guidelines recommend the use of either FOBT or endoscopic screening methods for the average-risk population [4]. In the European Union, the Advisory Committee on Cancer Prevention recommended FOBT as the primary screening method in 1999 [6]. This seems logical as large randomized trials have shown that screening with guaiac-based fecal occult blood testing (gFOBT) reduces CRC-related mortality [2] [7] [8] [9] and might also reduce the incidence of CRC [10]. In addition, there have been no randomized trials of the efficacy of colonoscopic screening. However, some experts consider colonoscopic screening methods to be more effective screening tools. This view is reflected in the guidelines from the American College of Gastroenterology and the German Society of Digestive and Metabolic Diseases (DGVS), which recommend colonoscopy as the preferred screening method [5] [11].

References

  • 1 The GLOBOCAN 2002 database: tables by population, regions and sex for Western Europe, Northern Europe, Southern Europe, Central and Eastern Europe (except Russian Federation). http://Available from http://www-dep.iarc.fr
  • 2 Mandel J S, Bond J H, Church T R. et al . Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study.  N Engl J Med. 1993;  328 1365-1371
  • 3 United States Preventive Task Force . Clinical guidelines: screening for colorectal cancer: recommendation and rationale.  Ann Intern Med. 2002;  137 129-131
  • 4 Winawer S, Fletcher R, Rex D. et al . Colorectal cancer screening and surveillance: clinical guidelines and rationale: update based on new evidence.  Gastroenterology. 2003;  124 544-560
  • 5 Rex D K, Johnson D A, Lieberman D A. et al . Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology.  Am J Gastroenterol. 2000;  95 868-877
  • 6 Advisory Committee on Cancer Prevention . Recommendations on cancer screening in the European Union. .  Eur J Cancer. 2000;  36 1473-1478
  • 7 Hardcastle J D, Chamberlain J O, Robinson M H. et al . Randomised controlled trial of faecal-occult-blood screening for colorectal cancer.  Lancet. 1996;  348 1472-1477
  • 8 Kronborg O, Fenger C, Olsen J. et al . Randomised study of screening for colorectal cancer with faecal-occult-blood test.  Lancet. 1996;  348 1467-1471
  • 9 Faivre J, Dancourt V, Lejeune C. et al . Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study.  Gastroenterology. 2004;  126 1674-1680
  • 10 Mandel J S, Church T R, Bond J H. et al . The effect of fecal occult-blood screening on the incidence of colorectal cancer.  N Engl J Med. 2000;  343 1603-1607
  • 11 Schmiegel W, Pox C, Adler G. et al . S3-Guidelines Conference “Colorectal Carcinoma” 2004 [in German, no abstract].  Z Gastroenterol. 2004;  42 1129-1177
  • 12 Knöpnadel J, Altenhofen L, Lichtner F, Brenner G. Zentralinstitut für die kassenärztliche Versorgung in der Bundesrepublik Deutschland. Früherkennung des Darmkrebses und möglicher Vorstufen: wissenschaftliche Begleitung zur Einführung der Früherkennungskoloskopie in Deutschland: Auswertungen der Dokumentationen zur Früherkennungskoloskopie Berichtszeitraum 2003. Köln; Deutscher Ärzte-Verlag 2005
  • 13 Sieg A, Brenner H. Screening colonoscopy in Germany is cost saving. Digestive Disease Week 2006; 2006 May 20 - 25. Los Angeles, California, USA. Poster T1393;
  • 14 Webendorfer S, Messerer P, Eberle F, Zober A. Precautions for intestinal cancer in the workplace: an initiative for secondary prevention in the BASF joint-stock company [in German, English abstract].  Dtsch Med Wochenschr. 2004;  129 239-243
  • 15 Brenner H, Chang-Claude J, Seiler C M. et al . Does a negative screening colonoscopy ever need to be repeated?.  Gut. 2006;  55 1145-1150
  • 16 Johns L E, Houlston R S. A systematic review and meta-analysis of familial colorectal cancer risk.  Am J Gastroenterol. 2001;  96 2992-3003
  • 17 Butruk E, Regula J, Polkowski M. et al . National colorectal cancer screening programme in Poland: ESGE newsletter.  Endoscopy. 2002;  34 939-940
  • 18 Regula J, Zagorowicz E, Butruk E. Implementation of a national colorectal cancer screening program.  Curr Colorectal Cancer Rep. 2006;  2 25-29
  • 19 Lieberman D A, Holub J, Eisen G. et al . Utilization of colonoscopy in the United States: results from a national consortium.  Gastrointest Endosc. 2005;  62 875-883
  • 20 Seeff L C, Manninen D L, Dong F B. et al . Is there endoscopic capacity to provide colorectal cancer screening to the unscreened population in the United States?.  Gastroenterology. 2004;  127 1661-1669
  • 21 Winawer S J, Zauber A G, Fletcher R H. et al . Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society.  Gastroenterology. 2006;  130 1872-1885
  • 22 Institute of Medicine and National Research Council of the National Academies .Economic models of colorectal cancer screening in average-risk adults: workshop summary. Washington DC; The National Academies Press 2005
  • 23 Imperiale T F, Wagner D R, Lin C Y. et al . Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings.  N Engl J Med. 2000;  343 169-174
  • 24 Lieberman D A, Weiss D G, Bond J H. et al . Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380.  N Engl J Med. 2000;  343 162-168
  • 25 Schoenfeld P, Cash B, Flood A. et al . Colonoscopic screening of average-risk women for colorectal neoplasia.  N Engl J Med. 2005;  352 2061-2068
  • 26 Winawer S J, Zauber A G, Ho M N. et al . Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.  N Engl J Med. 1993;  329 1977-1981
  • 27 Nelson D B, McQuaid K R, Bond J H. et al . Procedural success and complications of large-scale screening colonoscopy.  Gastrointest Endosc. 2002;  55 307-314
  • 28 Muller A D, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: a case-control study among veterans.  Arch Intern Med. 1995;  155 1741-1748
  • 29 Selby J V, Friedman G D, Quesenberry Jr C P, Weiss N S. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.  N Engl J Med. 1992;  326 653-657
  • 30 Brenner H, Arndt V, Sturmer T. et al . Long-lasting reduction of risk of colorectal cancer following screening endoscopy.  Br J Cancer. 2001;  85 972-976
  • 31 Citarda F, Tomaselli G, Capocaccia R. et al . Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence.  Gut. 2001;  48 812-815
  • 32 Atkin W, Cook C, Cuzick J. et al . Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial.  Lancet. 2002;  359 1291-1300
  • 33 Weissfeld J L, Schoen R E, Pinsky P F. et al . Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.  J Natl Cancer Inst. 2005;  97 989-997
  • 34 Leaper M, Johnston M J, Barclay M. et al . Reasons for failure to diagnose colorectal carcinoma at colonoscopy.  Endoscopy. 2004;  36 499-503
  • 35 Bressler B, Paszat L F, Vinden C. et al . Colonoscopic miss rates for right-sided colon cancer: a population-based analysis.  Gastroenterology. 2004;  127 452-456
  • 36 Pickhardt P J, Choi J R, Hwang I. et al . Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults.  N Engl J Med. 2003;  349 2191-2200
  • 37 Mysliwiec P A, Brown M L, Klabunde C N, Ransohoff D F. Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy.  Ann Intern Med. 2004;  141 264-271
  • 38 Brown M L, Klabunde C N, Mysliwiec P. Current capacity for endoscopic colorectal cancer screening in the United States: data from the National Cancer Institute survey of colorectal cancer screening practices.  Am J Med. 2003;  115 129-133

C. Pox, MD

Ruhr-Universität Bochum
Medizinische Klinik

Knappschaftskrankenhaus

In der Schornau 23 - 25

44892 Bochum

Germany

Fax: +49-234-299-3409

Email: Christian.P.Pox@ruhr-uni-bochum.de

    >